AMN Healthcare Services Sees Q2 Revenue $730M-$750M Vs $776.83M Est.
AMN Healthcare Services Sees Q2 Revenue $730M-$750M Vs $776.83M Est.
Second Quarter 2024 Outlook
2024 年第二季度展望
| Metric | Guidance* |
| Consolidated revenue | $730 - $750 million |
| Gross margin | 30.7% - 31.2% |
| SG&A as percentage of revenue | 21.5% - 22.0% |
| Operating margin | 3.0% - 3.7% |
| Adjusted EBITDA margin | 11.0% - 11.5% |
| 指標 | 指導* |
| 合併收入 | 7.30-7.5 億美元 |
| 毛利率 | 30.7%-31.2% |
| 銷售和收購佔收入的百分比 | 21.5%-22.0% |
| 營業利潤率 | 3.0%-3.7% |
| 調整後息折舊攤銷前利潤率 | 11.0%-11.5% |
*Note: Guidance percentage metrics are approximate. For a reconciliation of adjusted EBITDA margin, see the table entitled "Reconciliation of Guidance Operating Margin to Guidance Adjusted EBITDA Margin" below.
*注意：指導百分比指標是近似值。有關調整後息稅折舊攤銷前利潤率的對賬，請參閱下表 “指導營業利潤率與指導性調整後息稅折舊攤銷前利潤率的對賬”。
Revenue in the second quarter of 2024 is expected to be 24-26% lower than prior year and 9-11% lower sequentially. Nurse and Allied Solutions segment revenue is expected to be down 36-38% year over year. Physician and Leadership Solutions segment revenue is expected to grow approximately 10% year over year. Technology and Workforce Solutions segment revenue is projected to be approximately 12% lower year over year.
Second quarter estimates for certain other financial items include depreciation of $18 million, depreciation in cost of revenue of $1.8 million, non-cash amortization expense of $25 million, share-based compensation expense of $7 million, integration and other expenses of $7 million, interest expense of $16 million, an adjusted tax rate of 30%, and 38.3 million diluted average shares outstanding.
預計2024年第二季度的收入將比上年下降24-26％，環比下降9-11％。護士和聯合解決方案板塊的收入預計將同比下降36-38％。醫生和領導力解決方案板塊的收入預計將同比增長約10％。技術和勞動力解決方案板塊的收入預計將同比下降約12％。
第二季度某些其他財務項目的估計包括折舊1,800萬美元、收入成本折舊180萬美元、非現金攤銷費用2500萬美元、基於股份的薪酬支出700萬美元、整合和其他支出700萬美元、1,600萬美元的利息支出、30％的調整後稅率以及3,830萬股攤薄後的平均已發行股份。
譯文內容由第三人軟體翻譯。